Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Financial Results

 This is to inform you that the Board of Directors of the Company, at their meeting held today at 3 p.m. has Approved the Audited financial results of the Company for the quarter and year ended 31st March, 2019. The above financial Results along with the Auditor's Report on the Financial Results are enclosed herewith. We hereby declare that the Statutory Auditors of the Company have issued their audit report with unmodified opinion. The meeting of the Board of Directors was concluded at 5. 15 p.m. Kindly take the same on your records.
18-05-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Outcome of Board Meeting

 This is to inform you that the Board of Directors of the Company, at their meeting held today at 3 p.m. has: 1. Approved the Audited financial results of the Company for the quarter and year ended 31st March, 2019. 2. Approved the appointment of S K Pandey, Company Secretary in Practice as Secretarial Auditor of the Company u/s 204 of the Companies Act, 2013 for the financial Year 2019-20. 3. Approved the appointment of M/s CNK & Associates LLP, Chartered Accountants as Internal Auditor of the Company for the financial year 2019-20. The meeting of the Board of Directors was concluded at 5.15 p.m. The above financial Results along with the Auditor's Report on the Financial Results are enclosed herewith. We hereby declare that the Statutory Auditors of the Company have issued their audit report with unmodified opinion.
18-05-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Consideration Of Audited Financial Results For The Year Ended March 31, 2019

 Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2019 ,inter alia, to consider and approve the audited financial results of the Company for the fourth quarter and year ended March 31, 2019.
11-05-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that Mr. Balkrishana Talawadekar resigned as Chief Financial Officer of the Company with effect from close of business hours of May 18, 2019 due to personal reason. Request you to take the same on your record.
11-05-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliance Certificate For March 31, 2019

 We are enclosing herewith Compliance certificate under Regulation 7(3) of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015 for the half year ended March 31, 2019.
27-04-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Non-Applicability Of SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th Nov., 2018-Fund Raising By Issuance Of Debt Securities By Large Entities.

 With reference to SEBI Circular, SEBI/ HO/DDHS/CIR/P/2018/ 144 dated 26th November 2018- fund raising by issuance of debt securities by Large Entities, we would like to inform you that our company - Aspira Pathlab & Diagnostics Limited is "Not a Large Corporate" as per the framework provided in the aforesaid Circular. Kindly take the above in your records. Thanking you
27-04-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayAspira Pathlab & Diagnostics Ltd 2CININE500C01017 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 6 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Mamta Mav Designation: Company Secretary EmailId: info@aspiradiagnostics.com Name of the Chief Financial Officer: Balkrishna Talawadekar Designation: Chief Financial Officer EmailId: balkrishna.talawadekar@aspiradiagnostics.com Date: 27/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
27-04-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2019

 We send herewith a certificate for half-year ended March 31, 2019, duly signed by Mr. S.K. Pandey, Practicing Company Secretaries, pursuant to the provisions under Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking You
25-04-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we are forwarding herewith a copy of the certificate dated April 20, 2019, received from M/S. Sharex Dynamic (India) Pvt. Ltd. the Registrar and Transfer Agent of the Company, for the quarter ended 31st March, 2019. We request you to kindly take above on the records.
25-04-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended March 31, 2019

 Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
20-04-2019
Next Page
Close

Let's Open Free Demat Account